Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel.

Primo N LaraEdward MayersonErik GertzCatherine TangenAmir GoldkornMarta van LoanMaha H A HussainShilpa GuptaJingsong ZhangMamta ParikhPrzemyslaw TwardowskiDavid I QuinnMichael LeBlancIan ThompsonArchana M Agarwal

Published in: Prostate cancer and prostatic diseases (2024)

NCT01809691.

Keyphrases

phase iii
prostate cancer
open label
clinical trial
bone mineral density
phase ii
double blind
placebo controlled
soft tissue
small cell lung cancer
squamous cell carcinoma
radical prostatectomy
bone regeneration
bone loss
postmenopausal women
middle aged
randomized controlled trial